HJ Research delivers in-depth insights on the global Personalized Medicines market in its upcoming report titled, Global Personalized Medicines Market Report 2018-2029. According to this study, the global Personalized Medicines market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Personalized Medicines market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Personalized Medicines market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Personalized Medicines industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Personalized Medicines industry.
Global Personalized Medicines market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Personalized Medicines industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Personalized Medicines market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Personalized Medicines. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Personalized Medicines market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Personalized Medicines in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Personalized Medicines market include:
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
Market segmentation, by product types:
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Market segmentation, by applications:
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
1 Industry Overview of Personalized Medicines
1.1 Research Scope
1.2 Market Segmentation by Types of Personalized Medicines
1.3 Market Segmentation by End Users of Personalized Medicines
1.4 Market Dynamics Analysis of Personalized Medicines
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Personalized Medicines Industry
2.1 3G Biotech
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Quest Diagnostics
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Laboratory Corporation of America
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Abbott
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Agendia NV
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Asuragen Inc
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Becton Dickinson
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 CardioDx Inc.
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Foundation Medicine
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Qiagen
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.10.4 Contact Information
2.11 Siemens Healthcare
2.11.1 Company Overview
2.11.2 Main Products and Specifications
2.11.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.11.4 Contact Information
2.12 Amgen
2.12.1 Company Overview
2.12.2 Main Products and Specifications
2.12.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.12.4 Contact Information
2.13 Bristol-Myers Squibb
2.13.1 Company Overview
2.13.2 Main Products and Specifications
2.13.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.13.4 Contact Information
2.14 GE Healthcare
2.14.1 Company Overview
2.14.2 Main Products and Specifications
2.14.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.14.4 Contact Information
2.15 Pfizer
2.15.1 Company Overview
2.15.2 Main Products and Specifications
2.15.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.15.4 Contact Information
2.16 Sanofi
2.16.1 Company Overview
2.16.2 Main Products and Specifications
2.16.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.16.4 Contact Information
2.17 23andMe
2.17.1 Company Overview
2.17.2 Main Products and Specifications
2.17.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.17.4 Contact Information
2.18 Illumina
2.18.1 Company Overview
2.18.2 Main Products and Specifications
2.18.3 Personalized Medicines Revenue and Gross Margin (2018-2023)
2.18.4 Contact Information
3 Global Personalized Medicines Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Personalized Medicines by Regions (2018-2023)
3.2 Global Sales Revenue of Personalized Medicines by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Personalized Medicines by Types (2018-2023)
3.4 Global Sales Revenue of Personalized Medicines by End Users (2018-2023)
4 Northern America Personalized Medicines Market Analysis by Countries, Types and End Users
4.1 Northern America Personalized Medicines Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Personalized Medicines Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Personalized Medicines Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Personalized Medicines Sales Revenue Analysis (2018-2023)
4.5 Canada Personalized Medicines Sales Revenue Analysis (2018-2023)
5 Europe Personalized Medicines Market Analysis by Countries, Types and End Users
5.1 Europe Personalized Medicines Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Personalized Medicines Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Personalized Medicines Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Personalized Medicines Sales Revenue Analysis (2018-2023)
5.5 France Personalized Medicines Sales Revenue Analysis (2018-2023)
5.6 UK Personalized Medicines Sales Revenue Analysis (2018-2023)
5.7 Italy Personalized Medicines Sales Revenue Analysis (2018-2023)
5.8 Russia Personalized Medicines Sales Revenue Analysis (2018-2023)
5.9 Spain Personalized Medicines Sales Revenue Analysis (2018-2023)
5.10 Netherlands Personalized Medicines Sales Revenue Analysis (2018-2023)
6 Asia Pacific Personalized Medicines Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Personalized Medicines Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Personalized Medicines Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Personalized Medicines Sales Revenue Analysis by End Users (2018-2023)
6.4 China Personalized Medicines Sales Revenue Analysis (2018-2023)
6.5 Japan Personalized Medicines Sales Revenue Analysis (2018-2023)
6.6 Korea Personalized Medicines Sales Revenue Analysis (2018-2023)
6.7 India Personalized Medicines Sales Revenue Analysis (2018-2023)
6.8 Australia Personalized Medicines Sales Revenue Analysis (2018-2023)
6.9 Indonesia Personalized Medicines Sales Revenue Analysis (2018-2023)
6.10 Vietnam Personalized Medicines Sales Revenue Analysis (2018-2023)
7 Latin America Personalized Medicines Market Analysis by Countries, Types and End Users
7.1 Latin America Personalized Medicines Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Personalized Medicines Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Personalized Medicines Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Personalized Medicines Sales Revenue Analysis (2018-2023)
7.5 Mexico Personalized Medicines Sales Revenue Analysis (2018-2023)
7.6 Argentina Personalized Medicines Sales Revenue Analysis (2018-2023)
7.7 Colombia Personalized Medicines Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Personalized Medicines Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Personalized Medicines Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Personalized Medicines Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Personalized Medicines Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Personalized Medicines Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Personalized Medicines Sales Revenue Analysis (2018-2023)
8.6 South Africa Personalized Medicines Sales Revenue Analysis (2018-2023)
8.7 Egypt Personalized Medicines Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Personalized Medicines Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Personalized Medicines by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Personalized Medicines by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Personalized Medicines by End Users (2024-2029)
10.4 Global Revenue Forecast of Personalized Medicines by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Personalized Medicines
11.1 Upstream Analysis of Personalized Medicines
11.2 Downstream Major Consumers Analysis of Personalized Medicines
11.3 Major Suppliers of Personalized Medicines with Contact Information
11.4 Supply Chain Relationship Analysis of Personalized Medicines
12 Personalized Medicines New Project Investment Feasibility Analysis
12.1 Personalized Medicines New Project SWOT Analysis
12.2 Personalized Medicines New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Personalized Medicines Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Personalized Medicines
Table End Users of Personalized Medicines
Figure Market Drivers Analysis of Personalized Medicines
Figure Market Challenges Analysis of Personalized Medicines
Figure Market Opportunities Analysis of Personalized Medicines
Table Market Drivers Analysis of Personalized Medicines
Table 3G Biotech Information List
Figure Personalized Medicines Specifications of 3G Biotech
Table Personalized Medicines Revenue (Million USD) and Gross Margin of 3G Biotech (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of 3G Biotech (2018-2023)
Table Quest Diagnostics Information List
Figure Personalized Medicines Specifications of Quest Diagnostics
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Quest Diagnostics (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Quest Diagnostics (2018-2023)
Table Laboratory Corporation of America Information List
Figure Personalized Medicines Specifications of Laboratory Corporation of America
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Laboratory Corporation of America (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Laboratory Corporation of America (2018-2023)
Table Abbott Information List
Figure Personalized Medicines Specifications of Abbott
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Abbott (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Abbott (2018-2023)
Table Agendia NV Information List
Figure Personalized Medicines Specifications of Agendia NV
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Agendia NV (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Agendia NV (2018-2023)
Table Asuragen Inc Information List
Figure Personalized Medicines Specifications of Asuragen Inc
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Asuragen Inc (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Asuragen Inc (2018-2023)
Table Becton Dickinson Information List
Figure Personalized Medicines Specifications of Becton Dickinson
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Becton Dickinson (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Becton Dickinson (2018-2023)
Table CardioDx Inc. Information List
Figure Personalized Medicines Specifications of CardioDx Inc.
Table Personalized Medicines Revenue (Million USD) and Gross Margin of CardioDx Inc. (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of CardioDx Inc. (2018-2023)
Table Foundation Medicine Information List
Figure Personalized Medicines Specifications of Foundation Medicine
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Foundation Medicine (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Foundation Medicine (2018-2023)
Table Qiagen Information List
Figure Personalized Medicines Specifications of Qiagen
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Qiagen (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Qiagen (2018-2023)
Table Siemens Healthcare Information List
Figure Personalized Medicines Specifications of Siemens Healthcare
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Siemens Healthcare (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Siemens Healthcare (2018-2023)
Table Amgen Information List
Figure Personalized Medicines Specifications of Amgen
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Amgen (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Amgen (2018-2023)
Table Bristol-Myers Squibb Information List
Figure Personalized Medicines Specifications of Bristol-Myers Squibb
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Bristol-Myers Squibb (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Bristol-Myers Squibb (2018-2023)
Table GE Healthcare Information List
Figure Personalized Medicines Specifications of GE Healthcare
Table Personalized Medicines Revenue (Million USD) and Gross Margin of GE Healthcare (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of GE Healthcare (2018-2023)
Table Pfizer Information List
Figure Personalized Medicines Specifications of Pfizer
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Pfizer (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Pfizer (2018-2023)
Table Sanofi Information List
Figure Personalized Medicines Specifications of Sanofi
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Sanofi (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Sanofi (2018-2023)
Table 23andMe Information List
Figure Personalized Medicines Specifications of 23andMe
Table Personalized Medicines Revenue (Million USD) and Gross Margin of 23andMe (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of 23andMe (2018-2023)
Table Illumina Information List
Figure Personalized Medicines Specifications of Illumina
Table Personalized Medicines Revenue (Million USD) and Gross Margin of Illumina (2018-2023)
Figure Personalized Medicines Revenue (Million USD) and Global Market Share of Illumina (2018-2023)
Table Global Revenue (Million USD) of Personalized Medicines by Regions (2018-2023)
Table Global Revenue (Million USD) of Personalized Medicines by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Personalized Medicines by Types (2018-2023)
Table Global Revenue (Million USD) of Personalized Medicines by End Users (2018-2023)
Table Northern America Personalized Medicines Revenue (Million USD) by Countries (2018-2023)
Table Northern America Personalized Medicines Revenue (Million USD) by Types (2018-2023)
Table Northern America Personalized Medicines Revenue (Million USD) by End Users (2018-2023)
Figure United States Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Personalized Medicines Revenue (Million USD) by Countries (2018-2023)
Table Europe Personalized Medicines Revenue (Million USD) by Types (2018-2023)
Table Europe Personalized Medicines Revenue (Million USD) by End Users (2018-2023)
Figure Germany Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Personalized Medicines Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Personalized Medicines Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Personalized Medicines Revenue (Million USD) by End Users (2018-2023)
Figure China Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Personalized Medicines Revenue (Million USD) by Countries (2018-2023)
Table Latin America Personalized Medicines Revenue (Million USD) by Types (2018-2023)
Table Latin America Personalized Medicines Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Personalized Medicines Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Personalized Medicines Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Personalized Medicines Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Personalized Medicines Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Personalized Medicines by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Personalized Medicines by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Personalized Medicines by End Users (2024-2029)
Table Major Consumers with Contact Information of Personalized Medicines
Table Major Suppliers of Personalized Medicines with Contact Information
Figure Supply Chain Relationship Analysis of Personalized Medicines
Table New Project SWOT Analysis of Personalized Medicines
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Personalized Medicines
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Personalized Medicines Industry
Table Part of References List of Personalized Medicines Industry
Table Units of Measurement List
Table Part of Author Details List of Personalized Medicines Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Personalized Medicines industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Personalized Medicines market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Personalized Medicines manufacturers, Personalized Medicines raw material suppliers, Personalized Medicines distributors as well as buyers. The primary sources from the supply side include Personalized Medicines manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Personalized Medicines raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Personalized Medicines industry landscape and trends, Personalized Medicines market dynamics and key issues, Personalized Medicines technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Personalized Medicines competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Personalized Medicines market size and forecast by regions, Personalized Medicines market size and forecast by application, Personalized Medicines market size and forecast by types, Personalized Medicines company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
